Clinical Trial Update: Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating parathyroid hormone (PTH) for osteoporosis in postmenopausal women; the study has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Parathyroid Hormone (PTH) (parathyroid hormone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Postmenopausal Osteoporosis, Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2013-09-26